Clinical Trial Update: Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ramipril for claudication in peripheral arterial disease, studying effects on oxidative damage and muscle fibrosis; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Ramipril (ramipril)

Snippet

Sponsor: University of Nebraska | Conditions: Peripheral Arterial Disease | Phase 4 | Status: RECRUITING